Clenbuterol is not a medicine you will find on a Danish or UK pharmacy shelf for human use. It is a beta-2 agonist with a legitimate role in veterinary medicine for horses, and a long history of illicit use in bodybuilding and weight-loss circles. The side effects that users report—tremors, palpitations, sweating—are not random unpleasantries. They are direct evidence that the drug is stimulating the heart and nervous system in ways that can, at higher doses, cause serious harm.
Understanding what clenbuterol does to the body matters because the doses used outside medicine bear little resemblance to the therapeutic doses studied in animals. A 40 mcg tablet might sound modest. But case reports show that even a single 400 mcg dose—ten times the typical therapeutic amount—can land a healthy young man in hospital with myocarditis.
The Beta-2 Story: Why It Affects More Than the Airways
Clenbuterol works by stimulating beta-2 adrenergic receptors. In the lungs, this relaxes airway smooth muscle, which is why it is used in horses with respiratory disease. But beta-2 receptors are not confined to the airways. They are present in the heart, blood vessels, skeletal muscle, and the central nervous system.
The UK veterinary product information for clenbuterol lists the expected side effects in animals: sweating (mainly on the neck), muscle tremor, tachycardia, slight hypotension, and restlessness. It notes these are “typical for β-agonists”. The same receptor activity that opens airways in a horse also speeds up the heart and makes muscles twitch. In humans taking far higher doses for fat loss, those effects are amplified.
A review of clenbuterol toxicity in theHCA Healthcare Journal of Medicine describes the clinical picture: signs and symptoms range from simple nausea to myocardial ischemia, rhabdomyolysis, and cardiogenic shock. The authors note that presentations do not correlate neatly with the dose ingested—some people react severely to amounts that others tolerate.
Tremors and Palpitations: The Body Saying “Slow Down”
Tremor is one of the most commonly reported effects. It is a direct consequence of beta-2 stimulation in skeletal muscle. The veterinary label describes it as “muscle tremor,” and it appears in case series of human users as one of the hallmark symptoms alongside tachycardia and gastrointestinal disturbance.
Palpitations and a racing heart are equally characteristic. A 2008 review inScienceDirect on tainted street drugs listed tachycardia, palpitations, and hypokalemia among clenbuterol’s clinical effects, along with tachypnea, hypotension, agitation, lightheadedness, tremors, chest pain, and shortness of breath. The article also noted that cases of myocardial infarction following intentional clenbuterol misuse have been reported.
These are not abstract concerns. A 2022 case report inBMJ Case Reports described a man in his late twenties who took a single 400 mcg clenbuterol tablet to lose weight. He developed persistent chest pain, shortness of breath, sweating, restlessness, palpitations, and vomiting. Cardiac MRI showed myocardial oedema and delayed enhancement consistent with acute myocarditis. He was admitted to a cardiology ward and treated with beta-blockers and aspirin, and recovered—but the episode was entirely avoidable.
The Danish and UK Context: Legal, but Not Approved
The legal status of clenbuterol differs between the two countries, and neither is a green light for casual use.
In the UK, clenbuterol is a controlled drug under the Misuse of Drugs Regulations. It is not licensed for human use. The only UK-authorised products containing clenbuterol are veterinary medicines for horses, such as Ventipulmin and Equipulmin, and their labels explicitly warn that ingestion by humans can cause significant cardiovascular effects including elevated pulse rate, blood pressure changes, and ECG changes.
In Denmark, clenbuterol is not an approved human medicine at all. Its use falls under anti-doping legislation, and possession outside veterinary or research contexts carries legal risk. The Danish research funded by Anti Doping Danmark, cited in the earlier article on Astralean, found that a two-week course increased muscle mass but reduced the muscles’ ability to use oxygen—meaning fitness declined even as size increased.
The doses used in bodybuilding are the critical variable. Professor Ric Day, director of clinical pharmacology and toxicology at St Vincent’s Hospital in Sydney, told theMedical Journal of Australia that the prescribed bronchodilator dose is 20–40 mcg, but bodybuilders and weight-loss users take “orders greater than that.” He described the dosing as “total chaos” and emphasised the need for public awareness of the cardiac hazards.
What This Means for Anyone Considering Clenbuterol
The side effects of clenbuterol are not a sign that the drug is “working.” They are a sign that it is stressing systems that are not designed for chronic stimulation. Tremor, palpitations, sweating, and restlessness are the body’s visible response to beta-2 overstimulation. The invisible responses—hypokalemia, cardiac ischemia, myocardial inflammation—are the ones that put people in hospital.
A 40 mcg tablet is not a safe starting point simply because it is a round number. It is a dose that, in a veterinary context, is calibrated for a horse. In a human using it for fat loss, the therapeutic window is narrow and the consequences of overshooting are cardiovascular. The case reports exist because people have crossed that line, often without realising how far they had gone.
For adults in Denmark and the UK, the useful takeaway is that clenbuterol’s side effects are not a tolerable price for a cosmetic result. They are a warning system. Tremors and palpitations mean the drug is affecting the heart and nervous system in ways that can escalate. The safest response to those symptoms is not to push through—it is to stop and seek medical advice.




